|
|
|
0 members (),
1,046
guests, and
24
robots. |
|
Key:
Admin,
Global Mod,
Mod
|
|
S |
M |
T |
W |
T |
F |
S |
|
|
|
|
|
|
|
1
|
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
|
9
|
10
|
11
|
12
|
13
|
14
|
15
|
|
16
|
17
|
18
|
19
|
20
|
21
|
22
|
|
23
|
24
|
25
|
26
|
27
|
28
|
29
|
|
30
|
|
|
|
|
|
|
|
There are no members with birthdays on this day. |
#501751
Tue 07 May 2019 10:11:AM
|
Joined: Feb 2001
Posts: 381,904
Launch Director
|
OP
Launch Director
Joined: Feb 2001
Posts: 381,904 |
GV, Alphabet Inc's venture capital arm, led a $58.5 million investment to launch Verve Therapeutics, a new biotech focused on developing therapies that edit the human genome to treat heart diseases.  Source: Alphabet's GV leads funding in gene editing company Verve Therapeutics
|
|
CMS The Best Conveyancing solicitors conveyancing quotes throughout the UK
For any webhosting enquiries please email webmaster@aus-city.com
|
|
Entire Thread
|
Alphabet's GV leads funding in gene editing company Verve Therapeutics
|
Webmaster
|
Tue 07 May 2019 10:11:AM
|
|
Forums60
Topics750,156
Posts784,833
Members2,958
| |
Most Online8,388
Nov 28th, 2025
|
|
|
|
|
Copyright 1996 - 2024 by David Cottle. Designed by David Bate Jr. All Rights Reserved.
By using this forum, the user agrees not to transfer any data or technical information received under the agreement, to any other entity without the express approval of the AUS-CITY Forum Admins and/or authors of individual posts (Forum Admins and DoD/USSPACECOM for the analysis of satellite tracking data).
Two-line elements (TLE) and all other satellite data presented and distributed via this forum and e-mail lists of AUS-CITY are distributed with permission from DoD/USSTRATCOM.
Reprise Hosting
|
|
